These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 486619)

  • 21. Mild hyperphenylalaninemia and heterozygosity of the phenylalanine hydroxylase gene.
    Koch R; Güttler F; Guldberg P; Rouse B
    Mol Genet Metab; 1998 Feb; 63(2):148-50. PubMed ID: 9562969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gypsy phenylketonuria: a point mutation of the phenylalanine hydroxylase gene in Gypsy families from Slovakia.
    Kalanin J; Takarada Y; Kagawa S; Yamashita K; Ohtsuka N; Matsuoka A
    Am J Med Genet; 1994 Jan; 49(2):235-9. PubMed ID: 8116675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspartame loading test in PKU heterozygous individuals bearing severe and moderate mutations.
    da Silva LC; Carvalho TS; da Silva FB; Pires RF; Giugliani R; Pereira ML
    Clin Genet; 2000 Jul; 58(1):86-8. PubMed ID: 10945671
    [No Abstract]   [Full Text] [Related]  

  • 24. [Malignant forms of phenylketonuria].
    Bliumina MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(10):1462-5. PubMed ID: 6506948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of heterozygotes for phenylketonuria. Total body phenylalanine clearance and concentrations of phenylalanine and tyrosine in the plasms of fasting subjects compared.
    Jagenburg R; Regårdh CG; Rödjer S
    Clin Chem; 1977 Sep; 23(9):1654-60. PubMed ID: 890909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Maternal phenylketonuria].
    Rittinger O; Plöchl E; Jarosch E
    Padiatr Padol; 1984; 19(1):87-92. PubMed ID: 6701000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-phenylketonuria hyperphenylalaninaemia in Northern Ireland: frequent mutation allows screening and early diagnosis.
    Zschocke J; Graham CA; Stewart FJ; Carson DJ; Nevin NC
    Hum Mutat; 1994; 4(2):114-8. PubMed ID: 7981714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depressive symptoms in adolescents with early and continuously treated phenylketonuria: associations with phenylalanine and tyrosine levels.
    Sharman R; Sullivan K; Young RM; McGill J
    Gene; 2012 Aug; 504(2):288-91. PubMed ID: 22609065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intravenous phenylalanine loading test in normal subjects and the parents of phenylketonuretics].
    Badinand A; François R; Site J; Quincy C; Mamelle N; Masson E; Later R
    C R Seances Soc Biol Fil; 1968; 162(8):1525-8. PubMed ID: 4238174
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma phenylalanine, tyrosine, and tryptophan in schizophrenia.
    Potkin SG; Cannon-Spoor HE; DeLisi LE; Neckers LM; Wyatt RJ
    Arch Gen Psychiatry; 1983 Jul; 40(7):749-52. PubMed ID: 6860076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation analysis of the phenylalanine hydroxylase gene and its clinical implications in two Japanese patients with non-phenylketonuria hyperphenylalaninemia.
    Kibayashi M; Nagao M; Chiba S
    J Hum Genet; 1998; 43(4):231-6. PubMed ID: 9852673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Method of detection of heterozygotic carrier state in phenylketonuria].
    Baikov AD; Sitnichenko EI
    Lab Delo; 1973; 5():293-5. PubMed ID: 4129158
    [No Abstract]   [Full Text] [Related]  

  • 34. Discrimination of heterozygotes for phenylketonuria, persistent hyperphenylalaninemia and controls by phenylalanine loading.
    Blitzer MG; Bailey-Wilson JE; Shapira E
    Clin Chim Acta; 1986 Dec; 161(3):347-52. PubMed ID: 3802540
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma thiols and their determinants in phenylketonuria.
    Colomé C; Artuch R; Sierra C; Brandi N; Lambruschini N; Campistol J; Vilaseca MA
    Eur J Clin Nutr; 2003 Aug; 57(8):964-8. PubMed ID: 12879091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the brain barrier system function and changes of cerebrospinal fluid concentrations of phenylalanine and tyrosine in human phenylketonuria.
    Ratzmann GW; Grimm U; Jährig K; Knapp A
    Biomed Biochim Acta; 1984; 43(2):197-204. PubMed ID: 6732755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
    Trefz FK; Blau N
    Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intravenous loading of L-phenylalanine: detection of heterozygotes in phenylketonuria].
    Lambert J; Viailhet M; Monot C; Lepoire E; Baradel J; Nabet P; Martin J; Pierson M
    C R Seances Soc Biol Fil; 1973; 167(3):502-8. PubMed ID: 4785089
    [No Abstract]   [Full Text] [Related]  

  • 40. Heterozygous carriers of classical phenylketonuria in a sample of the Turkish population: detection by a spectrofluorimetric method.
    Güneral F; Ozalp I; Tatlidil H
    J Inherit Metab Dis; 1991; 14(5):741-8. PubMed ID: 1843186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.